Catalog No. : SER-0710-0140

Seraseq™ ctDNA Mutation Mix v2 AF 1%

Seraseq™ ctDNA Mutation Mix v2 AF 1%


To overcome the lack of patient-like reference materials for liquid biopsy, including drawbacks of existing methodologies such as sonication, SeraCare has developed a breakthrough technology that produces the most patient-like materials compared to native ctDNA. The Seraseq ctDNA Mutation Mix v2 is a highly multiplexed product for NGS-based ctDNA assays targeting cancer-relevant somatic mutations.

This specific ctDNA Mutation Mix v2 product has an allele frequency of 1%.

  • Size distribution, library yield and complexity consistent with native ctDNA
  • Single sample with 40 clinically-relevant mutations across 28 genes, all at the same specified allele frequency
  • Offered as a purified DNA mixture for ease of use during assay development
  • Mutation targets precisely quantitated with digital PCR
  • Single well-characterized GM24385 human genomic DNA as background wild-type material
  • Manufactured in GMP-compliant and ISO 13485-certified facilities
ItemSize Application Price
Seraseq™ ctDNA Mutation Mix v2 AF 1%

1 X 25uL

Next Gen Sequencing $1,412.00

# of variants
Allele Frequency
Fragment Size
170bp average
10 ng/µL 
250 ng (single vial)
1 mM Tris / 0.1 mM EDTA pH 8.0

Related Products

ItemSizeMakeCatalog No.ApplicationPriceQty
Seraseq™ ctDNA Mutation Mix v2 WT

1 X 25uL

SeraCare SER-0710-0144 Next Gen Sequencing
ItemSizeMakeCatalog No.ApplicationPriceQty
Seraseq™ ctDNA Complete™ Mutation Mix AF 1%

1 x 25 µL

SeraCare SER-0710-0530 Next Gen Sequencing